| |
| |
|
| Insider
Information: |
Allen Patricia L |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
19,793 |
|
|
Indirect Shares
|
653 |
|
|
| Direct
Value |
$22,762 |
|
|
|
Indirect Value
|
$97,924 |
|
|
| Total
Shares |
20,446 |
|
|
| Total
Value |
$120,686 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -44.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
VP of Finance/Treasurer |
2009-04-22 |
0 |
2009-04-22 |
653 |
Premium* |
|
|
Larimar Therapeutics Inc |
LRMR |
Chief Financial Officer |
2016-07-26 |
19,793 |
2016-07-25 |
0 |
Premium* |
|
|
Deciphera Pharmaceuticals, Inc. |
DCPH |
Director |
2020-06-05 |
0 |
2020-01-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DCPH |
Deciphera Pharmaceuticals... |
Director |
– • – |
2020-06-05 |
4 |
S |
$55.90 |
$314,999 |
D/D |
(5,635) |
0 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Director |
– • – |
2020-06-05 |
4 |
OE |
$25.73 |
$144,989 |
D/D |
5,635 |
5,635 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Director |
– • – |
2020-06-03 |
4 |
S |
$59.14 |
$376,450 |
D/D |
(6,365) |
0 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Director |
– • – |
2020-06-03 |
4 |
OE |
$25.73 |
$163,771 |
D/D |
6,365 |
6,365 |
0 |
- |
|
| DCPH |
Deciphera Pharmaceuticals... |
Director |
– • – |
2020-01-24 |
4 |
AS |
$65.93 |
$1,653,325 |
D/D |
(25,000) |
0 |
0 |
% |
|
| DCPH |
Deciphera Pharmaceuticals... |
Director |
– • – |
2020-01-24 |
4 |
OE |
$3.95 |
$98,750 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Financial Officer |
• – – |
2016-07-26 |
4 |
B |
$3.15 |
$25,830 |
D/D |
8,200 |
19,793 |
2.74 |
- |
|
| LRMR |
Larimar Therapeutics Inc |
Chief Financial Officer |
• – – |
2016-07-25 |
4 |
B |
$3.08 |
$24,032 |
D/D |
7,800 |
11,593 |
2.74 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
VP of Finance/Treasurer |
• – – |
2009-04-22 |
4 |
AS |
$17.63 |
$440,745 |
D/D |
(25,000) |
0 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
VP of Finance/Treasurer |
• – – |
2009-04-22 |
4 |
OE |
$0.95 |
$23,750 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
VP of Finance/Treasurer |
• – – |
2007-10-25 |
4 |
AS |
$32.06 |
$199,141 |
D/D |
(6,190) |
1,070 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
VP of Finance/Treasurer |
• – – |
2007-10-25 |
4 |
AS |
$31.54 |
$439,990 |
D/D |
(13,810) |
7,260 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
VP of Finance/Treasurer |
• – – |
2007-10-25 |
4 |
OE |
$0.95 |
$19,000 |
D/D |
20,000 |
21,070 |
0 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
officerTitle |
• – – |
2006-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,070 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
